Freshly Printed - allow 10 days lead
Couldn't load pickup availability
Recent Advances in Parkinson's Disease
Provides comprehensive coverage of the most recent and important advances in basic and translational research in Parkinson´s disease
Anders Bjorklund (Volume editor), Angela Cenci-Nilsson (Volume editor)
9780444642608, Elsevier Science
Hardback, published 2 April 2020
574 pages
23.4 x 19 x 3.2 cm, 1.34 kg
Recent Advances in Parkinson´s Disease Research, Volume 252, represents a follow-up on two previous volumes presented in the Progress in Brain Research series, Volumes 193 and 193, both published in 2010. It contains a collection of overview articles written by leading researchers in Parkinson's, discussing the most important advances made in basic, translational and clinical research. Topics of note in this new release include What can we learn from iPS cell models of PD, What can we learn from animal models of PD?, Molecular basis of selective neuronal vulnerability in PD, Role of innate and adaptive immunity in Parkinson´s disease, and much more.
What we can learn from iPSC-derived cellular models of Parkinson’s disease? Maria Claudia Caiazza, Charmaine Lang and Richard Wade-Martins 2. Animal models for preclinical Parkinson’s research: An update and critical appraisal M. Angela Cenci and Anders Björklund 3. Selective neuronal vulnerability in Parkinson’s disease Patricia Gonzalez-Rodriguez, Enrico Zampese and D. James Surmeier 4. Mechanisms of alpha-synuclein toxicity: An update and outlook Inês Caldeira Brás, Mary Xylaki and Tiago Fleming Outeiro 5. The role of glia in Parkinson’s disease: Emerging concepts and therapeutic applications Katarzyna Z. Kuter, M. Angela Cenci and Anna R. Carta 6. Innate and adaptive immune responses in Parkinson's disease Aubrey M. Schonhoff, Gregory P. Williams, Zachary D. Wallen, David G. Standaert and Ashley S. Harms 7. Pathways of protein synthesis and degradation in PD pathogenesis Rebekah G. Langston and Mark R. Cookson 8. Endosomal sorting pathways in the pathogenesis of Parkinson’s disease Lindsey A. Cunningham and Darren J. Moore 9. New players in basal ganglia dysfunction in Parkinson's disease Sara Meoni, Rubens Gisbert Cury and Elena Moro 10. Prodromal PD: A new nosological entity Eva Schaeffer, Ronald B. Postuma and Daniela Berg 11. The gut microbiome in Parkinson’s disease: A culprit or a bystander? Ali Keshavarzian, Phillip Engen, Salvatore Bonvegna and Roberto Cilia 12. Novel approaches to counter protein aggregation pathology in Parkinson's disease Simon R.W. Stott, Richard K. Wyse and Patrik Brundin 13. Repurposing anti-diabetic drugs for the treatment of Parkinson's disease: Rationale and clinical experience Tom Foltynie and Dilan Athauda 14. Basal ganglia oscillations as biomarkers for targeting circuit dysfunction in Parkinson's disease Per Petersson, Andre
Subject Areas: Neurosciences [PSAN], Physiological & neuro-psychology, biopsychology [JMM]
